HbA1C and cancer risk in patients with type 2 diabetes - a nationwide population-based prospective cohort study in Sweden

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Miao Jonasson, Junmei ^a,b   Cederholm, Jan ^c   Eliasson, Björn ^d   Zethelius, Björn ^c,e   Eeg Olofsson, Katarina ^d   Gudbjörnsdottir, Soffia ^a,d  

^a Center of Registers in Region Vastra Götaland   (Sweden)

^b SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; GYNECOLOGIC CANCER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROSPECTIVE STUDY; PROSTATE CANCER; RESPIRATORY TRACT CANCER; RISK ASSESSMENT; SMOKING; SWEDEN; URINARY TRACT CANCER;

DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84862260883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038784     Document Type: Article

References (36)

1. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. Diabetes care 33: 1674-1685.
2. Renehan A, Smith U, Kirkman MS, (2010) Linking diabetes and cancer: a consensus on complexity. Lancet 375: 2201-2202.
3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. CA: a cancer journal for clinicians 60: 207-221.
4. Smith U, Gale EA, (2010) Cancer and diabetes: are we ready for prime time? Diabetologia 53: 1541-1544.
5. Giovannucci E, Michaud D, (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132: 2208-2225.
6. Bunn HF, Gabbay KH, Gallop PM, (1978) The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 200: 21-27.
7. Stefansdottir G, Zoungas S, Chalmers J, Kengne AP, Knol MJ, et al. (2011) Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia 54: 1608-1614.
8. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
9. Johnson JA, Bowker SL, (2011) Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54: 25-31.
10. Lin J, Ridker PM, Pradhan A, Lee IM, Manson JE, et al. (2005) Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14: 3010-3012.
11. Lin J, Ridker PM, Rifai N, Lee IM, Manson JE, et al. (2006) A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer research 66: 2869-2875.
12. Platz EA, Hankinson SE, Rifai N, Colditz GA, Speizer FE, et al. (1999) Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer causes & control: CCC 10: 379-386.
13. Zhou XH, Qiao Q, Zethelius B, Pyorala K, Soderberg S, et al. (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53: 1867-1876.
14. Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, et al. (2009) Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52: 1745-1754.
15. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, et al. (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clinical chemistry 50: 166-174.
16. D'Agostino RB Jr, (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in medicine 17: 2265-2281.
17. Pencina MJ, Larson MG, D'Agostino RB, (2007) Choice of time scale and its effect on significance of predictors in longitudinal studies. Statistics in medicine 26: 1343-1359.
18. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, et al. (2007) Prospective study of hyperglycemia and cancer risk. Diabetes care 30: 561-567.
19. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA: the journal of the American Medical Association 293: 194-202.
20. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, et al. (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49: 945-952.
21. van Staa TP, Patel D, Gallagher AM, de Bruin ML, (2011) Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia.
22. Yang X, Ko GT, So WY, Ma RC, Yu LW, et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes 59: 1254-1260.
23. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, et al. (2009) Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 136: 1234-1241.
24. Yang YX, Habel LA, Capra AM, Achacoso NS, Quesenberry CP Jr, et al. (2010) Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19: 3027-3036.
25. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, et al. (2004) Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13: 915-919.
26. Rinaldi S, Rohrmann S, Jenab M, Biessy C, Sieri S, et al. (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17: 3108-3115.
27. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE, (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast cancer research and treatment 98: 349-356.
28. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE, (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98: 349-356.
29. Driver JA, Yung R, Gaziano JM, Kurth T, (2010) Chronic disease in men with newly diagnosed cancer: a nested case-control study. American journal of epidemiology 172: 299-308.
30. Fowke JH, Matthews CM, Buchowski MS, Signorello LB, Chang SS, et al. (2008) Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate cancer and prostatic diseases 11: 264-269.
31. Muller H, Raum E, Rothenbacher D, Stegmaier C, Brenner H, (2009) Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18: 1350-1356.
32. Ohwaki K, Endo F, Muraishi O, Yano E, (2011) Relationship between changes in haemoglobin A1C and prostate-specific antigen in healthy men. European journal of cancer 47: 262-266.
33. Ljung R, Talback M, Haglund B, Jonasson JM, Gudbjornsdottir S, et al. (2011) Insulin glargine use and short-term incidence of malignancies- a three-year population-based observation. Acta oncologica.
34. Yang X, So W, Ko GT, Ma RC, Kong AP, et al. (2008) Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 179: 427-437.
35. Best JD, O'Neal DN, (2000) Diabetic dyslipidaemia: current treatment recommendations. Drugs 59: 1101-1111.
36. Rothman KJ GS, (1998) Modern Epidemiology. Philadelphia: Lippincott Willians & Wilkins.